These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24190955)

  • 1. Using benefit-based tailored treatment to improve the use of antihypertensive medications.
    Sussman J; Vijan S; Hayward R
    Circulation; 2013 Nov; 128(21):2309-17. PubMed ID: 24190955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
    PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of Stratified Medicine for High Blood Pressure Management: A Modeling Study Using NHANES Survey Data.
    Porcher R; Tran VT; Blacher J; Ravaud P
    Hypertension; 2019 Dec; 74(6):1420-1427. PubMed ID: 31679427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive Medication Adherence and Risk of Cardiovascular Disease Among Older Adults: A Population-Based Cohort Study.
    Yang Q; Chang A; Ritchey MD; Loustalot F
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis.
    Pinho-Gomes AC; Azevedo L; Copland E; Canoy D; Nazarzadeh M; Ramakrishnan R; Berge E; Sundström J; Kotecha D; Woodward M; Teo K; Davis BR; Chalmers J; Pepine CJ; Rahimi K;
    PLoS Med; 2021 Jun; 18(6):e1003599. PubMed ID: 34061831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of initiation of antihypertensive therapy strategies for primary prevention of cardiovascular diseases in Chinese population: A decision-analytic Markov modelling study].
    Zhou T; Liu Q; Zhang M; Liu X; Kang J; Shen P; Lin H; Tang X; Gao P
    Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Jun; 56(3):441-447. PubMed ID: 38864129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada.
    Campbell NR; Brant R; Johansen H; Walker RL; Wielgosz A; Onysko J; Gao RN; Sambell C; Phillips S; McAlister FA;
    Hypertension; 2009 Feb; 53(2):128-34. PubMed ID: 19114646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
    Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
    PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Antihypertensive Medication Use Among Individuals With a History of Stroke and Hypertension, 2005 to 2016.
    Santos D; Dhamoon MS
    JAMA Neurol; 2020 Nov; 77(11):1382-1389. PubMed ID: 32716495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea.
    Liew D; Park HJ; Ko SK
    Clin Ther; 2009 Oct; 31(10):2189-203; discussion 2150-1. PubMed ID: 19922890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients.
    Suzuki H; Kanno Y;
    Hypertens Res; 2005 Apr; 28(4):307-14. PubMed ID: 16138560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy.
    Law M; Wald N; Morris J
    Health Technol Assess; 2003; 7(31):1-94. PubMed ID: 14604498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    Ko MJ; Jo AJ; Park CM; Kim HJ; Kim YJ; Park DW
    J Am Coll Cardiol; 2016 Jun; 67(24):2821-31. PubMed ID: 27311520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive Agents in Older Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Murad MH; Larrea-Mantilla L; Haddad A; Spencer-Bonilla G; Serrano V; Rodriguez-Gutierrez R; Alvarez-Villalobos N; Benkhadra K; Gionfriddo MR; Prokop LJ; Brito JP; Ponce OJ
    J Clin Endocrinol Metab; 2019 May; 104(5):1575-1584. PubMed ID: 30903690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Ventricular Wall Stress-Mass-Heart Rate Product and Cardiovascular Events in Treated Hypertensive Patients: LIFE Study.
    Devereux RB; Bang CN; Roman MJ; Palmieri V; Boman K; Gerdts E; Nieminen MS; Papademetriou V; Wachtell K; Hille DA; Dahlöf B
    Hypertension; 2015 Nov; 66(5):945-53. PubMed ID: 26418019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.